Ceruloplasmin and superoxide dismutase (SOD1) in Parkinson's disease: A follow-up study

Journal of the Neurological Sciences

Volumn 241, Issue 1-2, 2006, Pages 53-58

  Tórsdóttir, Gudlaug ^a,b   Sveinbjörnsdóttir, Sigurlaug ^b   Kristinsson, Jakob ^a   Snaedal, Jón ^b   Jóhannesson, Torkell ^a  

^a UNIVERSITY OF ICELAND   (Iceland)

^b LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

Author keywords

Ceruloplasmin; Hoehn and Yahr scores; Parkinson's disease; Superoxide dismutase

Indexed keywords

BROMOCRIPTINE; CARBOXYLYASE; CERULOPLASMIN; COPPER ZINC SUPEROXIDE DISMUTASE; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; MONOAMINE OXIDASE B INHIBITOR; PERGOLIDE; ROPINIROLE;

ADULT; AGED; ARTICLE; CERULOPLASMIN BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ERYTHROCYTE; FEMALE; FOLLOW UP; HUMAN; MALE; PARKINSON DISEASE; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CERULOPLASMIN; ERYTHROCYTES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; SERUM; SUPEROXIDE DISMUTASE;

EID: 30944455439     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2005.10.015     Document Type: Article

References (28)

1. M.C. de Rijk, C. Tzourio, M.M.B. Breteler, J.F. Dartigues, L. Amaducci, and S. Lopez-Pousa Rocca WA for the EUROPARKINSON study group. Prevalence of parkinsonism and Parkinson's diasease in Europe: the EUROPARKINSON collaborative study J Neurol Neurosurg Psychiatry 62 1997 10 15
2. A.J. Huges, S.E. Daniel, Y. Ben-Shlomo, and A.J. Lees The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service Brain 125 2002 861 870
3. D.T. Dexter, F.R. Wells, A.J. Lees, F. Agid, Y. Agid, and P. Jenner Increased nigral iron content and alteration in other metal ions occurring in brain in Parkinson's disease J Neurochem 52 1989 1830 1836
4. E. Floor, and M.G. Wetzel Increased protein oxidation in human substantia nigra pars compacta in comparison with basal ganglia and prefrontal cortex measured with an improved dinitrophenylhydrazine assay J Neurochem 70 1998 268 275
5. Z.I. Alam, S.E. Daniel, A.J. Lees, D.C. Marsden, P. Jenner, and B. Halliwell A generalised increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease J Neurochem 69 1997 1326 1329
6. J. Zhang, G. Perry, A.M. Smith, D. Robertson, S.J. Olson, and D.G. Graham Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons Am J Pathol 154 1999 1423 1429
7. P. Jenner Oxidative stress in Parkinson's disease Ann Neurol 53 Suppl. 3 2003 S26 S38
8. P.L. Fox, C. Mukhopadhyay, and E. Ehrenwald Structure, oxidant activity and cardiovascular mechanism of human ceruloplasmin Life Sci 56 1995 1749 1758
9. B.N. Patel, and S. Davis A novel glycosylphosphatidylinositol-anchored form of ceruloplasmin is expressed by mammalian astrocytes J Biol Chem 272 1997 20185 20190
10. D.A. Loeffler, P.A. Le Witt, P.L. Juneau, A.A.F. Sima, H.U. Nguyen, and A.J. DeMaggio Increased regional brain concentration of ceruloplasmin in neurodegenerative disorder Brain Res 738 1996 265 274
11. D.A. Loeffler, A.A.F. Sima, and P.A. LeWitt Ceruloplasmin immunoreactivity in neurodegenerative disorders Free Radic Res 35 2001 111 118
12. K. Yoshida, K. Kaneko, H. Miyajima, T. Tokuda, A. Nakamura, and M. Kato Increased lipid peroxidation in the brains of aceruloplasminemia patients J Neurol Sci 175 2000 91 95
13. B.N. Patel, R.J. Dunn, S.Y. Jeong, Q. Zhu, J.P. Julien, and S. David Ceruloplasmin regulates iron levels in the CNS and prevents free radical injury J Neurosci 22 2002 6578 6586
14. P.H. Evans Free radicals in brain metabolism and pathology Br Med Bull 49 1993 577 587
15. R.J. Martilla, H. Lorentz, and U.K. Rinne Oxygen toxicity protecting enzymes in Parkinson's disease J Neurol Sci 86 1988 321 331
16. H. Saggu, J. Cooksey, D. Dexter, F.R. Wells, A. Lees, and P. Jenner A selective increase in particulate superoxide dismutase activity in substantia nigra J Neurochem 53 1989 692 697
17. G. Tórsdóttir, J. Kristinsson, S. Sveinbjörnsdó ttir, J. Snaedal, and T. Jóhannesson Copper, ceruloplasmin, superoxide dismutase and iron parameters in Parkinson's disease Pharmacol Toxicol 85 1999 239 243
18. M.M. Hoehn, and M.D. Yahr Parkinsonism: onset, progression and mortality Neurology 17 1967 427 442
19. J.D. Boyett, H.P. Lehmann, and M.F. Beeler Automated assay of ceruloplasmin by kinetic analysis of o-dianisidine oxidation Acta Clin Chem 69 1976 233 241
20. C. Nebot, P. Moutet, P. Huet, J.Z. Xu, J.C. Yadan, and J. Chaudiere Spectrophotometric assay of superoxide dismutase activity based on the activated autoxidation of tetracyclic cathechol Anal Biochem 214 1993 442 451
21. E.G. Giannini, R. Testa, and V. Savarino Liver enzyme alteration: a guide for clinicians CMAJ 172 2005 367 379
22. G. Musci, M.C.B. di Patti, U. Fagiolo, and L. Calabrese Age-related changes in human ceruloplasmin J Biol Chem 268 1993 13388 13395
23. J.A. Molina-Arjona, F. de Bustos, J. Benito-León, F.J. Jiménez-Jiménez, J. Rodríguez, and R. Trincado Factores prooxidantes y antioxidantes séricos y riesgo para enfermedad de Parkinson: estudio poblacional Rev Neurol 29 1999 12 15 [Spanish]
24. K. Sudha, A.V. Rao, S. Rao, and A. Rao Free radical toxicity and antioxidants in Parkinon's disease Neurol India 51 2003 60 62
25. G. Campanella, P. Carrieri, D. Romito, and E. Pasqual-Marsettin Iron, transferrin, copper and ceruloplasmin of the serum and cerebrospinal fluid in extrapyramidal diseases and primary myopathies Acta Neurol (Napoli) 28 1973 1 34 [Italian]
26. Y. Ihara, M. Chuda, S. Kuroda, and T. Hayabara Hydroxyl radical and superoxide dismutase in blood of patients with Parkinson's disease: relationship to clinical data J Neurol Sci 170 1999 90 95
27. E. Martignoni, F. Blandini, L. Godi, S. Desideri, C. Pacchetti, and F. Mancini Peripheral markers of oxidative stress in Parkinson's disease. The role of L-dopa Free Radic Biol Med 27 1999 428 437
28. S. Bostantjopoulo, G. Kyriazis, Z. Katsarou, G. Kiosseoglou, A. Kazis, and G. Mentenopoulos Superoxide dismutase activity in early and advanced Parkinson's disease Funct Neurol 12 1997 63 67